The SATELLITE Trial: The Hidden Dimension of Hypertension Control
by Prateek Chopra | June 11, 2026 | Cardiology Conferences | ESH 2026 Therapeutic Objective: Evaluate the effects of telmisartan/amlodipine (T/A) and telmisartan/amlodipine/hydrochlorothiazide (T/A/HCTZ) SPCs on 24-hour blood pressure (BP), average real variability (ARV), and office BP control. Study Design: Baseline Characteristics: Key Findings: ARV Improvements: Clinical Implications: SATELLITE confirms that SPC therapy effectively reduces both BP and variability, highlighting additional […]
The SATELLITE Trial: The Hidden Dimension of Hypertension Control Read Post »